Marek Kovár
Department of Immunology and Gnotobiology
Institute of Microbiology
Academy of Sciences of the Czech Republic
v.v.i.
Czech Republic
Name/email consistency: high
- Overcoming immunoescape mechanisms of BCL1 leukemia and induction of CD8+ T-cell-mediated BCL1-specific resistance in mice cured by targeted polymer-bound doxorubicin. Kovar, M., Tomala, J., Chmelova, H., Kovar, L., Mrkvan, T., Joskova, R., Zakostelska, Z., Etrych, T., Strohalm, J., Ulbrich, K., Sirova, M., Rihova, B. Cancer Res. (2008)
- HPMA copolymers containing doxorubicin bound by a proteolytically or hydrolytically cleavable bond: comparison of biological properties in vitro. Kovár, M., Kovár, L., Subr, V., Etrych, T., Ulbrich, K., Mrkvan, T., Loucká, J., Ríhová, B. J. Control. Release (2004)
- HPMA copolymer-bound doxorubicin targeted to tumor-specific antigen of BCL1 mouse B cell leukemia. Kovár, M., Mrkvan, T., Strohalm, J., Etrych, T., Ulbrich, K., Stastný, M., Ríhová, B. J. Control. Release (2003)
- In vitro and in vivo effect of HPMA copolymer-bound doxorubicin targeted to transferrin receptor of B-cell lymphoma 38C13. Kovár, M., Strohalm, J., Ulbrich, K., Ríhová, B. J. Drug. Target (2002)